During the past decade, Teikyo University conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Teikyo University" are "Angina Pectoris" (1 trials), "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis" (1 trials), "Aortic Stenosis" (1 trials), "Coronary Artery Disease" (1 trials) and "Coronary Artery Occlusion" (1 trials). Many other conditions were trialed in "Teikyo University" in a lesser frequency.

Most popular intervention types in "Teikyo University" are "Device" (2 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ABSORB GT1 BVS" (1 trials), "Glucocorticoids" (1 trials), "Rituximab" (1 trials), "SAPIEN 3 THV" (1 trials) and "SAVR" (1 trials). Other intervention names were less common.

The vast majority of trials in "Teikyo University" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Teikyo University". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Teikyo University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Teikyo University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".